Drug Use Prevention Among Girls Through a Mother-Daughter Intervention
Drug Abuse Prevention: A Mother-Daughter Intervention
2 other identifiers
interventional
2,000
1 country
1
Brief Summary
This study will develop and test drug use prevention strategies for low-income, minority girls. Gender-specific substance use rates, risk and protective factors, and health outcomes highlight the need for interventions aimed at girls. Girls and boys share a number of risk factors, yet some factors are more salient for one gender. Girls and boys may also be affected differently by the same risk factors. Intervention planned for this study emphasizes risk and protective factors that impact girls. Our intervention will build mother-daughter communication and closeness; enhance girls' self-efficacy and body esteem; nurture girls' conflict management, problem-solving, stress reduction, and refusal skills; correct perceived norms; build social supports; and establish patterns of parental monitoring and supervision. We hypothesise that girls who receive GSI will have lower 3-year follow-up rates of substance use than girls who receive no intervention. The study will occur in three phases. In a 12-month preparation phase, we will refine and complete intervention and measurement protocols, recruit subjects and randomly assign girls and mothers to study arms, and pretest girls and mothers. A 12-month implementation phase will initiate field operations of the clinical trial, including intervention delivery, process data collection, and posttests. Follow-up in the last 36 months will involve longitudinal measurements of girls and mothers, booster session development and delivery, and data analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Apr 2005
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 30, 2006
CompletedFirst Posted
Study publicly available on registry
April 3, 2006
CompletedJanuary 11, 2017
March 1, 2006
March 30, 2006
January 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Scores on substance use behavior at posttest, and annually for 3 years after posttest.
Secondary Outcomes (10)
scores on mediating variables at posttest, and annually for 3 years after posttest.
closeness with mother
coping skills
refusal skills
depression (mood)
- +5 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- girls ages 11 to 13 years old at pretest and their mothers who have access to a private computer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University School of Social Work
New York, New York, 10027, United States
Related Publications (1)
Schinke S, Di Noia J, Schwinn T, Cole K. Drug abuse risk and protective factors among black urban adolescent girls: a group-randomized trial of computer-delivered mother-daughter intervention. Psychol Addict Behav. 2006 Dec;20(4):496-500. doi: 10.1037/0893-164X.20.4.496.
PMID: 17176186RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Schinke, Ph.D.
Columbia University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NIH
Study Record Dates
First Submitted
March 30, 2006
First Posted
April 3, 2006
Study Start
April 1, 2005
Study Completion
February 1, 2006
Last Updated
January 11, 2017
Record last verified: 2006-03